![Rosemonde Mandeville](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rosemonde Mandeville
Vorsitzender bei Biophage, Inc.
Aktive Positionen von Rosemonde Mandeville
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Armand-Frappier Foundation | Direktor/Vorstandsmitglied | 12.10.2011 | - |
Cancer Research Society
![]() Cancer Research Society Miscellaneous Commercial ServicesCommercial Services The Cancer Research Society is a non-profit organization that focuses on cancer research. The organization is based in Montreal, Canada. The organization has received support from Stéphane Rousseau, who is a spokesperson for the organization and actively supports their efforts. Max Fehlmann has been the CEO of the Canadian company since 2017. | Direktor/Vorstandsmitglied | 12.10.2011 | - |
Biophage, Inc.
![]() Biophage, Inc. Pharmaceuticals: MajorHealth Technology Biophage, Inc. develops pharmaceutical products. The company is headquartered in Montreal, Canada. | Vorsitzender | - | - |
Vorstandsvorsitzender | - | - | |
Technik-/Wissenschafts-/F&E-Leiter | - | - | |
Präsident | - | - |
Karriereverlauf von Rosemonde Mandeville
Ehemalige bekannte Positionen von Rosemonde Mandeville
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Montec Holdings, Inc. | Direktor/Vorstandsmitglied | - | 05.02.2009 |
Phagelux (Canada), Inc.
![]() Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - | - |
Biophage Pharma, Inc.
![]() Biophage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada. | Vorstandsvorsitzender | - | - |
Vorsitzender | 11.11.2009 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 11.11.2009 | - | |
Investor Relations Kontakt | 12.10.2011 | - | |
Präsident | 26.10.2001 | - |
Ausbildung von Rosemonde Mandeville
University of Manitoba | Doctorate Degree |
Alexandria University | Undergraduate Degree |
Statistik
International
Kanada | 8 |
2 |
Operativ
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Chairman | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Biophage Pharma, Inc.
![]() Biophage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada. | Health Technology |
Montec Holdings, Inc. | Technology Services |
Armand-Frappier Foundation | |
Cancer Research Society
![]() Cancer Research Society Miscellaneous Commercial ServicesCommercial Services The Cancer Research Society is a non-profit organization that focuses on cancer research. The organization is based in Montreal, Canada. The organization has received support from Stéphane Rousseau, who is a spokesperson for the organization and actively supports their efforts. Max Fehlmann has been the CEO of the Canadian company since 2017. | Commercial Services |
Biophage, Inc.
![]() Biophage, Inc. Pharmaceuticals: MajorHealth Technology Biophage, Inc. develops pharmaceutical products. The company is headquartered in Montreal, Canada. | Health Technology |
Phagelux (Canada), Inc.
![]() Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- Rosemonde Mandeville
- Erfahrung